Parallax Volatility Advisers’s Medicines Co MDCO Stock Holding History

Parallax Volatility Advisers’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,023,900	Closed	-$51.2M	–	2783
2019 Q3	$51.2M	Sell	1,023,900 -75,000	-7%	-$2.99M	0.06%	192
2019 Q2	$40.1M	Buy	1,098,900 +75,000	+7%	+$2.45M	0.04%	212
2019 Q1	$28.6M	Buy	1,023,900 +986,400	+2,630%	+$23.2M	0.03%	249
2018 Q4	$718K	Sell	37,500 -30,000	-44%	-$698K	﹤0.01%	1415
2018 Q3	$2.02M	Sell	67,500 -227,500	-77%	-$8.57M	﹤0.01%	1021
2018 Q2	$10.8M	Buy	+295,000	New	+$9.59M	0.02%	409
2017 Q3	–	Sell	-5,000	Closed	-$190K	–	3697
2017 Q2	$190K	Buy	+5,000	New	+$223K	﹤0.01%	1472
2016 Q3	–	Sell	-20,000	Closed	-$673K	–	4298
2016 Q2	$673K	Buy	+20,000	New	+$705K	﹤0.01%	1342
2015 Q3	–	Sell	-32,500	Closed	-$930K	–	4635
2015 Q2	$930K	Buy	+32,500	New	+$905K	﹤0.01%	1372

Other funds holding MDCO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

Parallax Volatility Advisers's MDCO Position: Q4 2019 in Review

Parallax Volatility Advisers sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 176,059 shares — an estimated $8.8M sold.

Parallax Volatility Advisers first reported a position in MDCO in Q1 2016 and held it in 8 quarters. The position peaked at $11.5M in Q2 2019. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

Parallax Volatility Advisers reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
Parallax Volatility Advisers sold 176,059 Medicines Co shares in Q4 2019, an estimated $8.8M.
Parallax Volatility Advisers first reported a position in Medicines Co in Q1 2016 and held it in 8 quarters.
Parallax Volatility Advisers's Medicines Co position peaked at $11.5M in Q2 2019.
284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on Parallax Volatility Advisers's 13F filing for Q4 2019, filed 14 Feb 2020.